Last update 01 Nov 2024

IDRX-42

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
+ [2]
Mechanism
TYK2 inhibitors(Tyrosine-protein kinase 2 inhibitors), Tyrosine kinase inhibitors, c-Kit inhibitors(Stem cell growth factor receptor inhibitors)
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
RegulationOrphan Drug (US)
Login to view timeline

Structure

Molecular FormulaC29H32N8O
InChIKeyLVMAULGVWBINFP-UHFFFAOYSA-N
CAS Registry2590556-80-0

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Gastrointestinal Stromal TumorsPhase 1
IT
03 Aug 2022
Gastrointestinal Stromal TumorsPhase 1
BE
03 Aug 2022
Neoplasm MetastasisPhase 1
ES
IDRx, Inc.IDRx, Inc.Startup
01 Aug 2022
Neoplasm MetastasisPhase 1
US
IDRx, Inc.IDRx, Inc.Startup
01 Aug 2022
Neoplasm MetastasisPhase 1
DE
IDRx, Inc.IDRx, Inc.Startup
01 Aug 2022
Neoplasm MetastasisPhase 1
BE
IDRx, Inc.IDRx, Inc.Startup
01 Aug 2022
Unresectable Gastrointestinal Stromal TumorPhase 1
US
IDRx, Inc.IDRx, Inc.Startup
01 Aug 2022
Unresectable Gastrointestinal Stromal TumorPhase 1
ES
IDRx, Inc.IDRx, Inc.Startup
01 Aug 2022
Unresectable Gastrointestinal Stromal TumorPhase 1
DE
IDRx, Inc.IDRx, Inc.Startup
01 Aug 2022
Unresectable Gastrointestinal Stromal TumorPhase 1
BE
IDRx, Inc.IDRx, Inc.Startup
01 Aug 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
73
(dgusdvjqtk) = vtuhjaglsd qnolvaaxso (vtgomueaaf )
Positive
03 Jul 2024
Phase 1
42
(nabfrzanqa) = xddvbwpbol wumklbfrrt (ekoqmgvwpd )
Positive
24 May 2024
(nabfrzanqa) = pdkqslqgxx wumklbfrrt (ekoqmgvwpd )
Phase 1
33
(voecgkefak) = NR qoffyarlvs (dyfjdxsjkq )
Positive
02 Nov 2023
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free